CLINICAL & PIPELINE·Clinical Trial
Qilu Hospital of Shandong University Initiates Phase 4 Trial for Lianhua Qingwen in Post-COVID Rehabilitation
Qilu Hospital of Shandong University has launched a Phase 4 clinical trial (NCT05625035) for Lianhua Qingwen capsules, targeting long-term coronavirus infection rehabilitation. This large-scale, randomized study, enrolling 4000 patients, aims to evaluate efficacy and safety, signaling a significant move in validating Traditional Chinese Medicine for post-viral syndromes and influencing future procurement strategies.
90-Day Activity